Vanda Pharmaceuticals (VNDA) Return on Capital Employed (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,144.00 |
| Dec 31, 2025 | -1,334.00 |
| Sep 30, 2025 | -457.00 |
| Jun 30, 2025 | -648.00 |
| Mar 31, 2025 | -603.00 |
| Dec 31, 2024 | -68.00 |
| Sep 30, 2024 | -89.00 |
| Jun 30, 2024 | -130.00 |
| Mar 31, 2024 | -202.00 |
| Dec 31, 2023 | -246.00 |
| Sep 30, 2023 | -178.00 |
| Jun 30, 2023 | -119.00 |
| Mar 31, 2023 | 175.00 |
| Dec 31, 2022 | -41.00 |
| Sep 30, 2022 | -135.00 |
| Jun 30, 2022 | -181.00 |
| Mar 31, 2022 | -347.00 |
| Dec 31, 2021 | -54.00 |
| Sep 30, 2021 | 31.00 |
| Jun 30, 2021 | 55.00 |
| Mar 31, 2021 | 197.00 |
| Dec 31, 2020 | 126.00 |
| Sep 30, 2020 | -84.00 |
| Jun 30, 2020 | -29.00 |
| Mar 31, 2020 | 37.00 |
| Dec 31, 2019 | -219.00 |
| Sep 30, 2019 | -12.00 |
| Jun 30, 2019 | 166.00 |
| Mar 31, 2019 | -199.00 |
| Dec 31, 2018 | 408.00 |
| Sep 30, 2018 | 427.00 |
| Jun 30, 2018 | 319.00 |
| Mar 31, 2018 | 904.00 |
| Dec 31, 2017 | -123.00 |
| Sep 30, 2017 | -285.00 |
| Jun 30, 2017 | 198.00 |
| Mar 31, 2017 | 127.00 |
| Dec 31, 2016 | 955.00 |
| Sep 30, 2016 | 609.00 |
| Jun 30, 2016 | 4.00 |
| Mar 31, 2016 | -308.00 |
| Dec 31, 2015 | -4,948.00 |
| Sep 30, 2015 | -507.00 |
| Jun 30, 2015 | 767.00 |
| Mar 31, 2015 | 554.00 |
| Dec 31, 2014 | 14,807.00 |
| Sep 30, 2014 | -3,696.00 |
| Jun 30, 2014 | -4,425.00 |
| Mar 31, 2014 | -3,159.00 |
| Dec 31, 2013 | 83.00 |
| Sep 30, 2013 | 317.00 |
| Jun 30, 2013 | 267.00 |
| Mar 31, 2013 | 68.00 |
| Dec 31, 2012 | -262.00 |
| Sep 30, 2012 | -361.00 |
| Jun 30, 2012 | -622.00 |
| Mar 31, 2012 | -633.00 |
| Dec 31, 2011 | -438.00 |